These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13221234)

  • 1. [In vitro studies on incorporation of radiocarbon-labeled mescaline and beta-phenylethylamine into proteins. IV. Incorporation in mitochondria, microsomes, cytoplasma and in cell nuclei].
    BLOCK W
    Hoppe Seylers Z Physiol Chem; 1954; 296(3-4):108-21. PubMed ID: 13221234
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro studies on incorporation of radiocarbon-labeled mescaline and beta-phenylethylamine into proteins. III..].
    BLOCK W
    Hoppe Seylers Z Physiol Chem; 1954; 296(1-2):1-10. PubMed ID: 13221221
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of mescaline and 3,4-dimethoxy-phenylethylamine in isolated brain mitochondria and brain homogenate.
    Shah NS; Himwich HE
    Brain Res; 1971 Nov; 34(1):163-70. PubMed ID: 5124914
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative metabolism of mescaline in the central nervous system. II. Oxidative deamination of mescaline and 2,3,4-trimethoxy-beta-phenylethylamine by different mouse brain area in vitro.
    Seiler N; Demisch L
    Biochem Pharmacol; 1971 Sep; 20(9):2485-93. PubMed ID: 5163157
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidative metabolism of mescaline in the central nervous system--V. In vitro deamination of mescaline to 3,4,5-trimethoxy-benzoic acid.
    Demisch L; Seiler N
    Biochem Pharmacol; 1975 Mar; 24(5):575-80. PubMed ID: 1125061
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of mescaline with subcellular fractions upon incubation of brain cortex slices with [14C] mescaline.
    Datta RK; Antopol W; Ghosh JJ
    Pharmacology; 1977; 15(3):283-7. PubMed ID: 866404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans.
    Friedhoff AJ; Hollister LE
    Biochem Pharmacol; 1966 Mar; 15(3):269-73. PubMed ID: 5911541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone].
    JATZKEWITZ H
    Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiological disposition of beta-phenylethylamine, 2,4,5-trimethoxyphenylethylamine, 2,3,4,5,6-pentamethoxyphenylethylamine and beta-hydroxymescaline in rat brain, liver and plasma.
    Cohen I; Fischer JF; Vogel WH
    Psychopharmacologia; 1974 Mar; 36(1):77-84. PubMed ID: 4838506
    [No Abstract]   [Full Text] [Related]  

  • 10. The roles of 3,4,5-trihydroxy-beta-phenethylamine and 3,4-dimethoxy-beta-phenethylamine in the biosynthesis of Mescaline.
    Paul AG; Rosenberg H; Khanna KL
    Lloydia; 1969 Mar; 32(1):36-9. PubMed ID: 5788765
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.
    Charalampous KD
    Behav Neuropsychiatry; 1971; 2(11):26-9 passim. PubMed ID: 5566331
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultraviolet absorption spectra of mescaline sulfate and betaphenylethylamine sulfate.
    SALOMON K; BINA AF
    J Am Chem Soc; 1946 Nov; 68(11):2403. PubMed ID: 21002245
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary studies of the sodium borohydride stabilizable binding of phenylethylamine and tyramine to brain preparations.
    Ungar F; Mosnaim AD; Ungar B; Wolf ME
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):427-34. PubMed ID: 653100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pink spot in schizophrenia.
    Br Med J; 1966 Jan; 1(5480):119. PubMed ID: 5901567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Two auto-observations of experimental mescaline intoxication].
    DELAY J; DENBER ; DENIKER P; RACLOT M; ROPERT M
    Ann Med Psychol (Paris); 1956 Jul; 114(2):306-9. PubMed ID: 13340395
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oscillopolarographic behavior of mescaline].
    KALAB D
    Pharmazie; 1956 Apr; 11(4):268-9. PubMed ID: 13322634
    [No Abstract]   [Full Text] [Related]  

  • 18. Mescaline: apotheosis of the devil's root.
    PEARSON J; DEWHURST K
    Ir J Med Sci; 1956 Mar; (363):139-43. PubMed ID: 13318766
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE FLUORIMETRIC DETERMINATION OF MESCALINE AND VARIOUS BETA-PHENETHYLAMINES].
    SEILER N; WIECHMANN M
    Hoppe Seylers Z Physiol Chem; 1964; 337():229-40. PubMed ID: 14316917
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiological concomitants of mescaline intoxication; a study of the effects upon normal subjects tested with submaximal doses.
    FEIGEN GA; ALLES GA
    J Clin Exp Psychopathol; 1955; 16(3):167-78. PubMed ID: 13263423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.